PA
PRTK

Parallel Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Parallel Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$1.66K Buy
2019
Q3 		– Sell
2019
Q2 		$1K Sell
2019
Q1 		$16K Buy
2018
Q4 		$11K Buy
2018
Q3 		$18K Buy
2018
Q2 		$7K Buy